T4-bacteriophage endonuclease V
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jul 1, 1996 (NCT00002811)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- liposomal t4n5
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00089180 | Phase 2 | Mar 1, 2004 | National Cancer Institute (NCI), University of Alabama, Birmingham |
| NCT00002811 | Phase 3 | Jul 1, 1996 | Applied Genetic Technologies Corp |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Applied Genetic Technologies Corp | For profit | 1 | 1 | 1 | 1996 |
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 2004 |
| University of Alabama, Birmingham | Academic/Hospital | 1 | 0 | 1 | 2004 |
3 organizations
Page 1 / 1